The Unified Protocol as an Internet-based Intervention for Emotional Disorders: Randomized Controlled Trial
Overview
This randomized controlled trial evaluates a 10-week internet-based adaptation of the Unified Protocol for individuals with anxiety, depressive, and somatic symptom disorders. The study reports significant improvements in symptom distress and affect markers compared to a waitlist control, with gains maintained at follow-up. The resource is intended for researchers and clinicians interested in transdiagnostic digital mental health interventions.
- ID
43021680cbee420a- Source org
- OpenAlex
- Author
- Carmen Schaeuffele (Freie Universität Berlin), Sophie Luise Homeyer (Freie Universität Berlin), Luis Perea (Freie Universität Berlin), Lisa Scharf (Freie Universität Berlin), Ava Schulz (University of Zurich), Christine Knaevelsrud (Freie Universität Berlin), Babette Renneberg (Freie Universität Berlin), Johanna Boettcher (Psychologische Hochschule Berlin)
- Published
- 2020-12-16
- OA status
- gold
- DOI
- 10.31234/osf.io/528tw
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 9
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:43021680cbee420a,
title = {The Unified Protocol as an Internet-based Intervention for Emotional Disorders: Randomized Controlled Trial},
author = {Carmen Schaeuffele and Sophie Luise Homeyer and Luis Perea and Lisa Scharf and Ava Schulz and Christine Knaevelsrud and Babette Renneberg and Johanna Boettcher},
year = {2020},
journal = {OpenAlex},
doi = {10.31234/osf.io/528tw},
url = {https://doi.org/10.31234/osf.io/528tw}
}RIS
TY - JOUR TI - The Unified Protocol as an Internet-based Intervention for Emotional Disorders: Randomized Controlled Trial AU - Schaeuffele, Carmen AU - Homeyer, Sophie Luise AU - Perea, Luis AU - Scharf, Lisa AU - Schulz, Ava AU - Knaevelsrud, Christine AU - Renneberg, Babette AU - Boettcher, Johanna PY - 2020 PB - OpenAlex DO - 10.31234/osf.io/528tw UR - https://doi.org/10.31234/osf.io/528tw ER -
APA
Schaeuffele, C., Homeyer, S. L., Perea, L., Scharf, L., Schulz, A., Knaevelsrud, C., Renneberg, B., & Boettcher, J. (2020). The Unified Protocol as an Internet-based Intervention for Emotional Disorders: Randomized Controlled Trial. OpenAlex. https://doi.org/10.31234/osf.io/528tw
Related entries
- The unified protocol as an internet-based intervention for emotional disorders: Randomized controlled trial
- Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial
- Unified protocol in online group versus blended format for treating emotional disorders in university students: Preliminary results on feasibility at 6‐month follow‐up
- The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders
- Reductions in transdiagnostic factors as the potential mechanisms of change in treatment outcomes in the Unified Protocol: a randomized clinical trial
- Systematic Review and Meta-analysis of the Efficacy and Effectiveness of the Unified Protocol for Emotional Disorders in Group Format for Adults
- Efficacy of an internet-based version of the unified protocol for transdiagnostic treatment of emotional disorders in adolescents (iUP-A): A randomized active-controlled trial
- Effectiveness of the internet-based Unified Protocol transdiagnostic intervention for the treatment of depression, anxiety and related disorders in a primary care setting: a randomized controlled trial
- Effectiveness of the Unified Protocol for transdiagnostic treatment of emotional disorders in group format in Spain: Results from a randomized controlled trial with 6-months follow-up
- Implementation, efficacy and cost effectiveness of the unified protocol in a blended format for the transdiagnostic treatment of emotional disorders: a study protocol for a multicentre, randomised, superiority controlled trial in the Spanish National Health System